ArticlePDF Available

Erectile Dysfunction: An Update

Authors:
4 Advances in Medical, Dental and Health Sciences Vol. 2 ● Issue 1 ● Jan-Mar 2019 ● www.amdhs.org
REVIEW ARTICLE
AMDHS ADVANCES IN MEDICAL, DENTAL
AND HEALTH SCIENCES
OPEN ACCESS
e-ISSN: 2581-8538
Received: 13 February 2019;
Accepted: 03 April 2019
*Correspondence to:
Mr. Saurabh Nimesh, M. Pharm.
(Pharmacology)
Email: nimeshmiet@gmail.com
Copyright: © the author(s), publisher and
licensee OZZIE Publishers. This is an open-access
article distributed under the terms of the Creative
Commons Attribution Non-Commercial License,
which permits unrestricted non-commercial use,
distribution, and reproduction in any medium,
provided the original work is properly cited.
This is an open access article distributed under the terms
of the Creative Commons Attribution-NonCommercial-
ShareAlike 4.0 License
Saurabh Nimesh*, Ravi Tomar, Manoj Kumar, Nitish Tyagi, Piyush Kumar Shukla
Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, NH-58 Baghpat Crossing Bypass,
Meerut, Uttar Pradesh, INDIA.
Abstract
Erectile dysfunction or Sexual dysfunction or male impotence is dened as the inability of a man to achieve and
maintain an erection sucient for mutually satisfactory intercourse with his partner. Sexual health and function
are important determinants of quality of life. ED is a signicant and common medical problem. An estimated 150
million men worldwide have some degree of ED, and more than twice that many are expected to be aected by
2025. Several orally active drugs Apomorphine sublingual, Sildenal, Vardenal, Tadalal and Avanal are currently
prescribed for the treatment of ED to improve the arterial blood ow to the penile tissue. Herbal medicinal plants
and their extracts have been used in traditional medicine in treatment of ED. These herbal medicinal drugs are
including Ginseng, Ashwagandha, Yohimbine, Safed musli, Shilajit, Ginkgo. The present review provides an overview
of the knowledge of ED or sexual dysfunction at the time.
Key words: Sildenal, Corpus cavernosum, Libido, Nitric oxide, Androgen.
Erectile Dysfunction: An Update
ACCESS THIS ARTICLE ONLINE
WWW.AMDHS.ORG
DOI :
10.5530/amdhs.2019.1.3
INTRODUCTION
The National Institutes of Health Consensus Development Conference
on Impotence (7 December 1992) has dened Erectile dysfunction (ED)
or impotence as the ‘inability to achieve and maintain a penile erection
adequate for satisfactory sexual relationship’.[1] Male sexual dysfunction may
be manifested in a variety of ways and the history is critical to the proper
classication and subsequent treatment. Androgens have a strong inuence
on the sexual desire of men. A loss of libido may indicate androgen deciency
on the basis of either hypothalamic, pituitary or testicular disease.[2] This
denition better encompasses the full spectrum of activity that is affected by
ED (Figure 1), as opposed to denitions considering only vaginal penetration.
Sexual health is an important determinant of quality of life.[3] Today, millions
of men (young and old) suffer from ED due to high levels of synthetic
hormones (known as Xenoestrogens) in our diet/environment, nutritionally
imbalanced diet resulting from poor quality of produces and extremely low
levels of testosterone. ED is a pervasive problem among men worldwide.
According to World Health Organization ‘Sexual health is fundamental to
the physical or emotional health and wellbeing of individuals, couples and
families and to the social or economic development of communities and
countries’.[4] ED affects the quality of life for both patients and partners and
is associated with relationship difculties (Figure 2).[5-8]
Epidemiology
ED is a signicant and common medical problem. An estimated 150 million
men worldwide have some degree of ED (Figure 3) and more than twice
that many are expected to be affected by 2025. Recent studies suggest that
approximately 10% of men aged 40 to 70 have severe or complete ED,
dened as the total inability to achieve or maintain erections sufcient
for sexual performance.[9] An additional 25% of men in this age category
have moderate or intermittent erectile difculties. The disorder is highly
age dependent, as the combined prevalence of moderate to complete ED
rises from approximately 22% at age 40 to 49% by age 70. Although less
common in younger men, ED still affects 5 to 10% of men below the age
of 40. Findings from these studies show that ED impacts signicantly on
mood state, interpersonal functioning and overall quality of life (Figure 4).[10-13]
Mechanism
The proper functioning of the sexual apparatus is dependent not only on
its nervous and muscular integrity, but also on the endocrinal and psychic
factors.[14] Other systems of the body are complementary and their disorders
Published by : OZZIE PUBLISHERS
Nimesh.: Erectile Dysfunction
Advances in Medical, Dental and Health Sciences Vol. 2 ● Issue 1 ● Jan-Mar 2019 ● www.amdhs.org 5
penis. The result is the thickening, rigidity and elongation of the penis. An
erector muscle of the penis (ischiocavernosus) draws the penis forward and
makes it well adapted for penetration of the vagina.[17]
Orgasm and Ejaculation
Friction between the glans penis and vaginal mucosa, reinforced by several
other afferent stimuli and psychogenic factors, causes a reex discharge along
the sympathetic to the seminal pathway, the muscle coats of the epididymis,
ductus deferens, the seminal vesicles and the prostate gland. The sperm,
along with the secretion of the accessory glands, are discharged into the
posterior urethra, between the internal and external sphincter of the bladder.
After orgasm is reached, the rhythmic contractions of the bulbocavernous
and ischiocavernous muscles ejaculate the semen through the penis into
the vagina. Sympathetic nerves, which act as a motor to the seminal tract,
simultaneously close the internal vesicle sphincter and thus prevent a reex
of semen into the bladder. Further, the contraction of detrusor vesicae
and the associated inhibition of constrictor vesicae prevent a simultaneous
discharge of urine.[18]
Libido
The cerebral cortex is the chief controlling focus of the sex apparatus. Libido
is the conscious feeling of the sexual urge, which originates in the brain
center through the impulses received by various sense organs. In the event
of aroused libido, the brain center sends impulses to the spinal center, which
in turn passes them expeditiously to the peripheral nerves of the penis.[19]
Copulation
After the penis is inserted in the vagina, an act of sexual intercourse or
Figure 1: Spectrum of Erectile dysfunction.
Figure 2: Types of erectile dysfunction..
Figure 3: Erectile dysfunction prevalence by age and country.
Figure 4: Prevalence of sexual dysfunction (difference in
problems reported by men and women).
Figure 5: Mechanism of erection.
may ultimately affect this phenomenon, causing ED. Thus, erection is a
complex, involuntary, neuropsychological, hormone mediated vascular
event that happens when blood ows rapidly into the penis and becomes
trapped in its spongy chamber (Figure 5). Its precise erudition may add to
the comprehension of the physiological phenomenon, comprising libido,
erection, copulation, orgasm and the ejaculation.[15,16]
Erection
The preceding activities of the nerve endings cause dilatation of arterioles
by relaxing their smooth muscle coat, which in turn causes lling of the
spaces of corpora cavernosa resulting in its expansion. Accordingly, strong
pressure is exerted on the veins that normally drain blood from the penis.
The pressure is adequate to close the veins thus trapping the blood in the
Nimesh.: Erectile Dysfunction
6 Advances in Medical, Dental and Health Sciences Vol. 2 ● Issue 1 ● Jan-Mar 2019 ● www.amdhs.org
Table 1: Drugs causing and contributing to ED.
S. No. Drugs
1Antiparkinson
2Anticonvulsants
3Cytotoxic agents
4Analgesics
5Alcohol, nicotine and illicit drugs
6Antihypertensives
7Diuretics
8 Antipsychotics
copulation takes place and continues until the time of orgasm and
subsequent ejaculation.[20]
Detumescence
After ejaculation and cessation of exotic stimuli, sympathetic tonic
discharge resumes, this results in the contraction of smooth muscles
around sinusoidal spaces and arterioles. Arterial ow is diminished to
accid levels, much of the blood from sinusoidal spaces is expelled and
the venous channels are restored.[21]
Aetiology
Many factors can affect a man’s ability to get and keep an erection (Figure
6), drug also that may cause and contribute to ED (Table 1).[22,23]
Sign and Symptoms
The genitalia should be examined, noting the presence of penile scarring
or plaque formation (Peyronie’s disease) and any abnormalities in size
Table 3: List of herbal medicinal plants.
S.
No.
Biological
name Family Common
name Part used
1Panax ginseng Araliaceae Ginseng Root
2Withania somnifera
Linn. Solanaceae Ashwagandha Leaf and root
3Chlorophytum
tuberosum Baker. Liliaceae Safed musli Whole plant
4Asphaltum bitumen
--- Shilajit Pitch
5Ginkgo Biloba Ginkgoaceae Ginkgo Leaf and
seeds
6Pausinystalia
yohimbe Rubiaceae Yohimbine Bark
7Dactylorhiza
hatagirea Orchidaceae Salem panja Root
8Asparagus
racemosus Liliaceae Shatawari Root
9Fadogia agrestis
Schweinf. Ex Heim Rubiaceae Black
aphrodisiac Stem
Figure 6: Physiological causes ED.
or consistency of either testicle. Examination of the prostate is essential
(Figure 7).[24]
Laboratory ndings
Laboratory evaluation is limited and should consist of a complete blood
count, urinalysis and lipid prole, determination of serum testosterone or
prolactin. Patients with abnormalities of testosterone or prolactin require
further evaluation with measurement of serum follicle-stimulating hormone
and luteinizing hormone and endocrinologic consultation is advised.
Treatment
The vast majority of men suffering from ED can be treated successfully
with one of the approaches outlined below. Men who do not suffer from
organic dysfunction will probably benet from behaviourally oriented sex
therapy (Table 2).[25] The herbal medicinal plants have been traditionally
used for the treatment of ED or sexual dysfunction (Table 3).[26]
Table 2: Allopathic treatment for ED.
S.
No.
Allopathy
therapy
Side effect
1 Sildenal Warmth or redness in the face, neck or chest,
memory problems and upset stomach
2Tadalal Flu-like symptoms (such as stuffy nose, sneezing or
sore throat), Sudden decreased vision and low blood
pressure
3Vardenal Nausea, sweating, general ill feeling, irregular
heartbeat, swelling in your hands, ankles or feet and
shortness of breath
4Avanal Bronchitis, joint pain, high blood pressure and an
erection that will not go away (priapism)
5Apomorphine
sublingual
Nausea, dizziness, severe sweating and drowsiness.
6Lidocaine-
prilocaine cream
Redness, swelling, tingling/burning and lightening
of the skin
7Vacuum
constriction
devices
A black and blue mark or small area of bruising on
the shaft of the penis.
8Intracavernous
and intraurethral
therapy
Hypotension, reex tachycardia, nasal congestion
and gastrointestinal upset
9 Penile prostheses Injury to a vein or artery of lower extremity,
mechanical failure of the implant, severe pain
(temporary) in the surgical area
Nimesh.: Erectile Dysfunction
Advances in Medical, Dental and Health Sciences Vol. 2 ● Issue 1 ● Jan-Mar 2019 ● www.amdhs.org 7
CONCLUSION
Sexual problems are related to sexual desire and male ED. Successful
treatment of ED or sexual dysfunction may improve not only sexual
relationships, but also the overall quality of life. Thus, this review has dealt
with various approaches by which the screening of Allopathic drug and
herbal medicinal plants can be achieved. The rationale for the use of these
medicines is based on the speculation that some forms of male infertility are
caused by oxidative insult and hormonal imbalance and the use of oriental
medicine may improve male fertility potential and semen quality.
ACKNOWLEDGEMENT
Author would like to thank to Manoj Kumar, Ravi Tomar, Nitish Tyagi and
Piyush Kumar Shukla of B. Pharm nal year students of Meerut Institute of
Engineering and Technology Meerut (Uttar Pradesh), India; for their support
and helpful in cooperation in the data collection process.
CONFLICT OF INTEREST
The Authors declare that there is no conict of interest.
ABBREVIATIONS
ED: Erectile Dysfunction, WHO: World Health Organization.
REFERENCES
1. Wang J, Zhou Y, Dai H. The safety and efcacy of acupuncture for erectile
dysfunction: A Network meta-analysis. Medicine. 2019;98(2):1-4.
2. Burnett AL, Nehra A, Breau RH. Erectile dysfunction: AUA guideline. J Urol.
2018;200(3):633-41.
3. Pozzi E, Capogrosso P, Chierigo F. Clinical prole of young patients with erectile
dysfunction: Preliminary ndings of a real-life cross sectional study. Eur Urol
Focus. 2018.
4. Kalka D, Womperski M, Gebala J. 564 Do socioeconomic factors inuence the
pathogenesis of erectile dysfunction through modiable risk factors?. J Sex
Med. 2018;15(7):S335.
5. Jisheng W, Hengheng D, Bin W, et al. Comparison of TCM and western medicine
diagnosis and treatment strategies for erectile dysfunction. Chinese J Hum Sex.
2017;26:23-6.
6. Rongmin J, Yu Q, Tao W. Meta-analysis of clinical effectiveness of the acupuncture
treatment for erectile dysfunction. Chinese J Hum Sex. 2018;27:82-5.
7. Kaminetsky JC, Stecher V, Tseng LJ. Quality of erections by age group in men
with erectile dysfunction. Int J Clin Pract. 2017;71(10):e12976.
8. Wang X, Wang MLI. Discussing on the action mechanism of two-way adjustment
of acupuncture. J Sichuan Tradit Chinese Med. 2017;35:40-2.
9. Onyeji IC, Sui W, Pagano MJ. Impact of surgeon case volume on reoperation
rates after inatable penile prosthesis surgery. J Urol. 2017;197(12):223-9.
10. Cocci A, Russo GI, Salonia A. Predictive factors of patients and their partners
sexual function improvement after collagenase clostridium histolyticum injection
for Peyronie’s disease: Results from a multi-center single-arm study. J Sex Med.
2018;15(5):716-21.
11. Ren H, Zhang Q, Wang J. Comparative effects of umbilical cord- and menstrual
blood-derived MSCs in repairing acute lung injury. Stem Cells Int. 2018;2018.
12. Deng C, Wang L, Feng J, Lu F. Treatment of human chronic wounds with
autologous extracellular matrix/stromal vascular fraction gel: A STROBE-
compliant study. Medicine (Baltimore). 2018;97(32).
13. Sarwer DB, Wadden TA, Spitzer JC. 4-Year changes in sex hormones, sexual
functioning and psychosocial status in women who underwent bariatric surgery.
Obes Surg. 2018;28(4):892-9.
14. Lunsen RHW, Zimmerman Y, Coelingh BHJT. Maintaining physiological
testosterone levels by adding dehydroepiandrosterone to combined oral
contraceptives: II. Effects on sexual function. Contraception. 2018;98:56-62.
15. Ahlers CJ, Schaefer GA, Mundt IA. How unusual are the contents of paraphilias?
Paraphilia-associated sexual arousal patterns in a community-based sample of
men. J Sex Med. 2011;8(5):1362-70.
16. McPhail IV. Age of onset in pedohebephilic interests. Arch Sex Behav. 2018;1-5.
17. Tozdan S, Kalt A, Keller LB. Keep faith in yourself! -A pilot study on the relevance
of specic self-efcacy for modifying sexual interest in children among men with
a risk to sexually abuse children. J Sex Marital Ther. 2018;6:1-14.
18. Corona G, Maggi M, Jannini EA. EDEUS, a real-life study on the users of
phosphodiesterase type 5 inhibitors: Prevalence, perceptions and health care-
seeking behavior among European men with a focus on 2nd-generation avanal.
Sex Med. 2018;6(1):15-23.
19. Hutchings DC, Anderson SG, Caldwell JL, et al. Phosphodiesterase-5 inhibitors
and the heart: Compound cardioprotection?. Heart. 2018;104(15):1244-50.
20. Jo JK, Jeong SJ, Oh JJ, et al. Effect of starting penile rehabilitation with sildenal
immediately after robot-assisted laparoscopic radical prostatectomy on erectile
function recovery: A prospective randomized trial. J Urol. 2018;199(6):1600-6.
21. Goethe VE, Angerer H, Dinkel A. Concordance and discordance of sexual identity,
sexual experience and current sexual behavior in 45-year old men: Results from
the German Male Sex-Study. Sex Med. 2018;6(4):282-90.
22. Lane-Cordova AD, Kershaw K, Liu K. Association between cardiovascular health
and endothelial function with future erectile dysfunction: The Multi-Ethnic Study
of Atherosclerosis. Am J Hypertens. 2017;30(8):815-21.
23. Osondu CU, Vo B, Oni ET. The relationship of erectile dysfunction and subclinical
cardiovascular disease: A systematic review and meta-analysis. Vasc Med.
2018;23(1):9-20.
24. Aversa A, Fittipaldi S, Francomano D. Tadalal improves lean mass and
endothelial function in nonobese men with mild ED/LUTS: in vivo and in vitro
characterization. Endocrine. 2017;56(3):639-48.
25. Amano T, Earle C, Imao T. Administration of daily 5 mg tadalal improves
endothelial function in patients with benign prostatic hyperplasia. Aging Male.
2018;21(1):77-82.
26. Mulhall JP, Carlsson M, Stecher V. Predictors of erectile function normalization in
men with erectile dysfunction treated with placebo. J Sex Med. 2018;15(6):866-
72.
Figure 7: Symptoms of ED.
Cite this article as: Nimesh S. Erectile Dysfunction: An Update. Adv. Med. Dental Health Sci. 2019;2(1):4-7.
... Rối loạn cương dương được định nghĩa là không có khả năng đạt được và duy trì độ cương cứng của dương vật đủ để thỏa mãn quan hệ tình dục. 1 Tác giả Shiri và cộng sự (2007) đã báo cáo có tới 42% người bệnh trầm cảm mắc rối loạn cương dương. 2 Liu và cộng sự (2018) cũng đã chứng minh nguy cơ mắc rối loạn cương dương tăng 39% ở người bệnh trầm cảm và tỉ lệ mắc rối loạn cương dương ở người bệnh trầm cảm cao hơn 1,39 lần so với những người không mắc trầm cảm, 3 gây ra nhiều hậu quả làm giảm năng suất làm việc cũng như chất lượng cuộc sống của người bệnh và bạn tình. ...
... Cùng với sự phát triển của cuộc sống hiện đại, sức khỏe tâm thần ngày càng trở nên quan trọng và nhận được mối quan tâm của cộng đồng. Theo Tổ chức Y tế thế giới (WHO), sức khỏe tâm thần là một phần không thể thiếu đối với sức khỏe và hạnh phúc nói chung, và là một quyền cơ bản của con người [1]. Ngay từ năm 2001, WHO cũng đã nêu bật tầm quan trọng của sức khỏe tâm thần thông qua một báo cáo toàn diện đầu tiên để đưa ra các khuyến nghị cấp thiết cho các quốc gia cần bắt tay hành động sớm để giảm thiểu gánh nặng do bệnh lý về sức khỏe tâm thần. ...
Article
Mục tiêu: Phân tích một số yếu tố liên quan đến rối loạn cương dương ở người bệnh rối loạn trầm cảm tái diễn điều trị ngoại trú. Đối tượng và phương pháp nghiên cứu: Nghiên cứu mô tả cắt ngang 103 người bệnh rối loạn trầm cảm tái diễn điều trị ngoại trú tại Phòng khám chuyên khoa Tâm thần– Bệnh viện Bạch Mai từ tháng 08/2022 đến tháng 08/2023. Kết quả: Có 57,3% người bệnh có rối loạn cương dương. Có mối liên quan giữa rối loạn cương dương với tuổi (OR logistic = 2,83; 1,83 – 4,39), trình độ học vấn (OR = 4,17; 1,79 – 9,72), tình trạng hôn nhân (OR = 3,72; 1,51 – 9,2), số lần quan hệ tình dục (OR = 4,77; 1,84 – 12,42), thủ dâm (OR = 2,69; 1,18 – 6,13), thời gian diễn biến trầm cảm (OR = 6,32; 2,64 – 15,14) và sử dụng SSRIs (OR = 2,59; 1,00 – 6,72); không tìm thấy mối liên quan giữa các yếu tố tôn giáo, khu vực sống, tuổi quan hệ tình dục, số đối tác tình dục, số đợt trầm cảm trước với rối loạn cương dương. Kết luận: Có mối liên quan giữa các yếu tố tuổi, trình độ học vấn, tình trạng hôn nhân, số lần quan hệ tình dục, thủ dâm, thời gian diễn biến trầm cảm và sử dụng SSRIs với rối loạn cương dương ở người bệnh rối loạn trầm cảm tái diễn điều trị ngoại trú. Không tìm thấy mối liên quan giữa các yếu tố tôn giáo, khu vực sống, tuổi quan hệ tình dục, số đối tác tình dục, số đợt trầm cảm trước với rối loạn cương dương ở nhóm người bệnh này.
... Theo ước tính đến năm 2025, có khoảng 322 triệu nam giới mắc RLCD trên toàn thế giới [3]. Theo như một nghiên cứu tỉ lệ RLCD trên toàn thế giới dao động từ khoảng 3-76,5%, tỉ lệ cao nhất là các nước khu vực châu Âu chiếm 10-76,5%, khu vực châu Á chiếm 8-71,2%, khu vực châu Phi 24-58,9%, khu vực Bắc Mỹ chiếm 20,7-57,8% và thấp nhất là khu vực Nam Mỹ 14-55,2% [4]. ...
Article
Mục tiêu: Nghiên cứu tổng quan về vai trò của y học cổ truyền trong điều trị rối loạn cương dương tại Việt Nam Phương pháp: Nghiên cứu tổng quan luận điểm Kết quả: Trong 33 bài báo tìm được trên cơ sở dữ liệu, lọc ra được 5 bài báo phù hợp với tiêu chuẩn lựa chọn, trong đó chủ yếu là can thiệp lâm sàng, so sánh trước sau điều trị. Kết luận: Các nghiên cứu Y học cổ truyền trong điều trị rối loạn cương dương chủ yếu tập trung đánh giá hiệu quả của các bài thuốc cổ phương nhưng số lượng còn rất ít. Chưa có nhiều các nghiên cứu thực nghiệm.
... Theo ước tính đến năm 2025, có khoảng 322 triệu nam giới mắc rối loạn cương dương trên toàn thế giới. Rối loạn cương dương có thể ảnh hưởng đến sức khỏe tâm lý xã hội và có tác động đáng kể đến chất lượng cuộc sống của bệnh nhân và bạn tình của họ [1]. Thuốc ức chế men Phosphodiesterase type 5 (PDE-5) đã trở thành lựa chọn chính trong điều trị RLCD vì tính hiệu quả, dễ dung nạp, an toàn và dễ sử dụng. ...
Article
Đặt vấn đề: Rối loạn cương dương là một trong những rối loạn hoạt động tình dục phổ biến ở nam giới. Rối loạn cương có thể ảnh hưởng đến sức khỏe tâm lý và có tác động đáng kể đến chất lượng cuộc sống của bệnh nhân và bạn tình của họ. Tadalafil là lựa chọn đầu tay trong điều trị rối loạn cương dương vì tính hiệu quả, dễ dung nạp, an toàn và dễ sử dụng. Liều khởi đầu sử dụng thuốc 10mg trước quan hệ và sau đó điều chỉnh theo đáp ứng của bệnh nhân nhưng liều dùng tối ưu từng nhóm bệnh rối loạn cương dương chưa được nghiên cứu. Mục tiêu nghiên cứu: Đánh giá kết quả điều trị Tadalafil trên bệnh nhân rối loạn cương tại bệnh viện Đa khoa Trung Ương Cần Thơ và Bệnh viện Trường Đại học Y Dược Cần Thơ năm 2022-2023. Đối tượng và phương pháp nghiên cứu: Nghiên cứu cắt ngang tiến cứu trên 62 bệnh nhân đến khám vì rối loạn cương dương và được điều trị bằng Tadalafil liều khởi đầu 10mg trước quan hệ. Sau 3 lần dùng thuốc nếu không cải thiện chúng tôi tăng liều lên 20mg. Kết quả: Có 62 bệnh nhân nam được đưa vào nghiên cứu, trong đó độ tuổi trung bình 44.67 ± 12.16 tuổi. Mức độ cải thiện chức năng cương ở liều 20mg tốt hơn liều 10mg (p=0.07) và ở nhóm bệnh nhân rối loạn cương dương nặng liều 20mg tác dụng tốt hơn liều 10mg (p=0.001). Kết quả điều trị tốt chiếm 69.4%; trung bình chiếm 16.1%; không cải thiện chiếm 14.5%. Kết luận: Tadalafil là thuốc điều trị có hiệu quả trên hầu hết các nhóm bệnh nhân rối loạn cương từ nhẹ đến nặng. Nhóm rối loạn cương nhẹ, vừa liều Tadalafil 10mg là tối ưu, nhóm rối loạn cương nặng liều Tadalafil 20mg là tối ưu.
... Rối loạn cương dương (RLCD)là rối loạn tình dục phổ biến ở nam giới. Theo ước tính đến năm 2025, số lượng nam giới mắc RLCD sẽ đạt 322 triệu người [1]. Mặc dù RLCD không ảnh hưởng tới các chức năng thực thể nhưng lại có thể gây ảnh hưởng sâu sắc tới đời sống tinh thần của nam giới cũng như hạnh phúc gia đình họ. ...
Article
Rối loạn cương dương (RLCD) là một rối loạn tình dục phổ biến, gây ảnh hưởng đến chất lượng cuộc sống của bệnh nhân cũng như của đối tác. Nhiều nghiên cứu chỉ ra rằng rối loạn cương dương có thể dẫn đến trầm cảm (TC) khiến cho việc điều trị trở nên phức tạp và kém hiệu quả hơn. Chúng tôi tiến hành nghiên cứu trên 131 nam giới được chẩn đoán rối loạn cương dương để đánh giá trầm cảm và các yếu tố liên quan. Kết quả nghiên cứu của chúng tôi cho thấy tuổi trung bình của nhóm bệnh nhân có rối loạn cương dương là 45 ± 14,8. Tỉ lệ trầm cảm của những bệnh nhân rối loạn cương dương là 38,2%. Các yếu tố bao gồm tuổi dưới 40, không kết hôn và thủ dâm làm tăng nguy cơ xuất hiện của trầm cảm (p<0,05).
... Erectile Dysfunction is defined as the persistent failure to sustain a penile erection of adequate rigidity for sexual intercourse. [1,2] On the other hand, impotence is reserved for those males who suffer erectile failure for the period of intercourse most of the time or (75%) of the time. Currently, ER is the recognized term used since (1992), when the National Institutes of Health (NIH) Consensus Development Conference recommended it. ...
Article
Full-text available
There is no agreed management for Erectile Dysfunction (ED) for male patients with Diabetes Mellitus (DM). Regular Physical Exercise (PE) starts to be a more exciting area that needs further focus. This review attempts to gather available data about the ED burden, etiology, risk factors, assessment, and management. Further, it highlights the available evidence on the effect of PE on the progression of ED and the possible underline mechanisms. The available evidence is hugely supportive of the beneficial role of PE in the ED. The cardiovascular, neurological, endothelial, metabolic, and overall health benefits of PE are repeated mechanisms reported by many researchers. The possible explanation is quite not clear due to the complexity and bidirectional effect on many aspects related to the changes during PE. Further interventional studies are needed to determine the superiority of each factor. All physicians managing DM and ED are strongly invited to involve PE as part of their management plan in conjunction with other available treatment options. Research has to look after which type, duration, frequency, and intensity of PE is sufficient for detectable improvement in ED.
Article
Full-text available
The first common thing is Avanafil, Tadalafil and Sildenafil drugs are used to treat or cure to the male erectile dysfunction (ED). These drugs are available in the form of tablets have various brand name. Oral phosphodiesterase type 5 inhibitors (PDE5-Is) are considered to be effectual procedure for the cure of treatment of erectile dysfunction. Three of these drugs avanafil, tadalafil and sildenafil are recommended by the European Medicines Agency (EMA) and the Food and Drug Administration (FDA) for the treatment of erectile dysfunction. Erectile Dysfunction (ED) Erectile dysfunction is a multifaceted but usually in male sexual dysfunction that involves an alteration in any of the components of the erectile response, including organic, relational, biological and psychological factor. Erectile dysfunction is interpreted as the powerlessness to sustain an erection well enough to execute intercourse and ejaculation. Erectile dysfunction is a very usual disorder of male sexual desire, influence all age groups with a considerable impact on quality of life. It is also knowing as the impotency or persistent inability to reach or keeping penile erection enough for adequate sexual pleasure or performance. The Erectile dysfunction Influences more than 30 million men per year; yet only about 2 lakhs seek help from a physician. Erectile dysfunction rest globally unnoticed simply because many men do not talk about sexual complication with their physician. According to recent research all men will experience some stage of sexual issue or complication at one time to another, at most those who are not able to have desired intercourse 70 to 80 % of the time are considered impotent. Penile erection is a multiplex activity involving interactions between biological, neural, psychological, vascular, and hormonal elements. The avenue of usual sexual function in males consists of four steps: sexual desire/drive, erection, ejaculation/orgasm and detumescence (penile flaccidity). In the over, ED was observed, in most instance, to be a completely psychogenic disorder, but various evidence suggests that about 80% of cases have an organic aetiology. Causes of organic erectile dysfunction can now be widely classify into nonendocrine and endocrine. The nonendocrine aetiologies, vasculogenic (hit hard to blood supply) is the most usual and can mean arterial inflow disorders and oddity of venous outflow there are also neurogenic (affecting innervation and nervous function) and iatrogenic (relating to a medical or surgical care) aetiologies. In terms of endocrine element prime to erectile dysfunction, decrease serum testosterone levels have been indicate, but the exact procedure has not been fully elucidated. Often, organic erectile dysfunction involves a psychological component; that is, nevertheless of the involving event, erectile dysfunction imposes gloomy effects on interpersonal relationships, temper and quality of life.
Article
Full-text available
Background: Erectile dysfunction is a common male disease, the constant pace of life, increasing pressure on life, and changes in diet, living environment, lifestyle, etc., lead to an increase in the number of patients with erectile dysfunction (ED). Acupuncture has been widely used in clinical trials of ED in recent years. There are many clinical trials that confirm that acupuncture can improve male erectile function. This study used a network meta-analysis (NMA) to compare the effectiveness and safety of different forms of acupuncture on ED. Methods: We will search for PubMed, Cochrane Library, AMED, EMBASE, WorldSciNet; Nature, Science online and China Journal Full-text Database (China National Knowledge Infrastructure), China Biomedical Literature CD-ROM Database (CBM), and related randomized controlled trials (RCTs) included in the China Resources Database. The time is limited from the construction of the library to December 2018. The quality of the included RCTs will be evaluated with the risk of bias tool and evidence will be evaluated by Grading of Recommendations Assessment, Development and Evaluation. STATA 13.0 and WinBUGS 1.4.3 through the GeMTC package will be used to perform an NMA to synthesize direct and indirect evidence.
Article
Full-text available
Background: Erectile dysfunction (ED) is an increasingly common complaint among men aged <40 yr. Objective: To assess clinical factors potentially associated with impaired erectile function (EF) in a cohort of young men seeking first medical help for ED as their primary complaint. Design, setting, and participants: Complete sociodemographic and clinical data for 307 consecutive patients aged <40 yr were analysed. Health-significant comorbidities were scored using the Charlson comorbidity index. Patients completed the International Index of Erectile Function (IIEF) and Beck's Inventory for Depression (BDI) and were categorised into two groups: those with impaired EF (IIEF-EF <26) and those with normal IIEF-EF scores. Outcome measurements and statistical analysis: Descriptive statistics and logistic regression analyses were used to test the association between risk factors and impaired EF. Results and limitations: Overall, 78 patients (25%) had normal and 229 (75%) had impaired IIEF-EF scores. Among ED patients, 90 (29%) had IIEF-EF scores suggestive of severe ED. The two cohorts did not differ in terms of median age, body mass index, prevalence of hypertension, general health status, smoking history, or alcohol use. No differences were reported for serum sex hormones and lipid profiles. Patients with ED reported higher median BDI scores (7, interquartile range [IQR] 3-13) than those with normal EF (5, IQR 1-9). Overall, the higher the BDI score, the lower was the IIEF-EF domain score (odds ratio 1.08, 95% confidence interval 1.02-1.15; p=0.01). The single-centre cohort is the main study limitation. Conclusions: Overall, young men with impaired EF showed comparable clinical characteristics to those with normal IIEF-EF; conversely, young individuals with worse EF had BDI scores suggestive of significant mood deflection. Patient summary: Young men complaining of erectile dysfunction show significant mood deflection in comparison to patients with normal erectile function. Conversely, the clinical characteristics are similar between the two groups.
Article
Full-text available
Introduction: Discordance of various aspects of sexual orientation has been mostly studied in young adults or in small samples of heterosexual men. Studies focusing on concordance and discordance of aspects of sexual orientation in representative samples of middle-aged men including homosexual men are scarce. Aim: To investigate concordant and discordant sexual behavior in 45-year-old German men with a special focus on homosexual identified men. Methods: Data for this cross-sectional study were collected within the German Male Sex-Study. Participants were 45-year-old Caucasian males from the general population. Men self-reported on sexual identity, sexual experience, and current sexual behavior. Associations between sexual identity, experience, and behavior were analyzed using the chi-square test. Main outcome measure: Associations of sexual identity with sexual experience and behavior in a community-based sample of men, and discordance of sexual identity and behavior especially in the subgroup of homosexual men. Results: 12,354 men were included in the study. 95.1% (n = 11.749) self-identified as heterosexual, 3.8% (n = 471) as homosexual, and 1.1% (n = 134) as bisexual. Sexual identity was significantly associated with sexual experience and behavior. 85.5% of all men had recently been sexually active, but prevalence of sexual practices varied. In hetero- and bisexuals, vaginal intercourse was the most common sexual practice, whereas oral sex was the most common in homosexuals. A discordance of sexual identity was especially found in homosexual men: 5.5% of homosexuals only had sexual experiences with women, and 10.3% of homosexuals recently had vaginal intercourse. In this latter subgroup, only one-quarter ever had sexual experience with a man, and three-quarters had only engaged in sexual activity with a woman. Conclusion: Sexual identity is associated with differences in sexual experience and behavior in German middle-aged men. A considerable proportion of homosexual identified men live a heterosexual life. Goethe VE, Angerer H, Dinkel A, et al. Concordance and Discordance of Sexual Identity, Sexual Experience, and Current Sexual Behavior in 45-Year-Old-Men: Results From the German Male Sex-Study. Sex Med 201;X:XXX-XXX.
Article
Full-text available
Stem cell therapy is considered as the most promising treatment for chronic wounds. Extracellular matrix/stromal vascular fraction gel (ECM/SVF gel), an adipose-derived stem cell-based cytotherapy, has shown healing potential in experimental wounds in animal models. However, the effects of ECM/SVF gel on human chronic wounds have not been investigated. The aim of the present study is to investigate the therapeutic effect of ECM/SVF gel on human chronic wounds. Autologous ECM/SVF gel was prepared and used to treat patients with chronic wounds in clinics, with negative pressure wound therapy as the positive control. Wound healing rate per week and histological changes were performed. The average wound healing rate per week in the ECM/SVF gel group was 34.55 ± 11.18% compared with 10.16 ± 2.67% in the negative pressure wound therapy group (P < .001). Histological analysis with hematoxylin and eosin, Masson's trichrome staining, and CD31 immunohistochemistry showed less lymphocyte infiltration, more collagen accumulation, and more newly formed vessels in the ECM/SVF gel group treated skins compared to the control. ECM/SVF gel is an effective therapeutic option for chronic wound healing in clinics.
Article
Full-text available
Mesenchymal stem cells (MSCs) can effectively relieve acute lung injury (ALI) in several in vivo models. However, the underlying mechanisms and optimal sources of MSCs are unclear. In the present study, we investigated the effects of umbilical cord- (UC-) and menstrual blood- (MB-) derived MSCs on ALI. MSCs were transplanted into a lipopolysaccharide-induced ALI mouse model, and the therapeutic effects were determined by histological, cellular, and biochemical analyses. Our results showed that both UCMSC and MBMSC transplantation inhibited the inflammatory response and promoted lung tissue repair. UCMSC treatment resulted in reduced damage and inflammation in the lung tissue and enhanced protection of lung function. Furthermore, we found that UCMSCs secreted higher levels of anti-inflammatory cytokines (interleukin-10 and keratinocyte growth factor) in ALI-related conditions, which may be due to the greater therapeutic capacity of UCMSCs compared with MBMSCs. These findings suggest that MSCs protected the lipopolysaccharide-induced ALI model by regulating inflammation, most likely via paracrine factors. Moreover, MSCs derived from the UC may be a promising alternative for ALI treatment.
Article
Full-text available
Purpose: The purpose of this guideline is to provide a clinical strategy for the diagnosis and treatment of erectile dysfunction. Materials & methods: A systematic review of the literature using the Pubmed, Embase, and Cochrane databases (search dates 1/1/1965 to 7/29/17) was conducted to identify peer-reviewed publications relevant to the diagnosis and treatment of erectile dysfunction. Evidence-based statements were based on body of evidence strength Grade A, B, or C and were designated as Strong, Moderate, and Conditional Recommendations with additional statements presented in the form of Clinical Principles or Expert Opinions. Results: The American Urological Association has developed an evidence-based guideline on the management of erectile dysfunction. This document is designed to be used in conjunction with the associated treatment algorithm. Conclusions: Using the shared decision-making process as a cornerstone for care, all patients should be informed of all treatment modalities that are not contraindicated, regardless of invasiveness or irreversibility, as potential first-line treatments. For each treatment, the clinician should ensure that the man and his partner have a full understanding of the benefits and risk/burdens associated with that choice.
Article
Full-text available
Recent scholarship has examined the age of onset of pedohebephilic interests. While the issue of when such sexual interests begins is important to understand the development of minor attraction, there are noteworthy problems in the literature. As a result, clear explication of a few inter-related issues relevant to the age of onset of pedohebephilic interests appears warranted. This Letter aims to outline and provide commentary on some of these issues and contribute a more nuanced understanding of age of onset for pedohebephilic men and women.
Article
Background: Clinical study and practice data have shown sildenafil improves sexual function in men with erectile dysfunction (ED). However, some men treated with placebo in double-blind, placebo-controlled sildenafil studies also report improved erectile function as measured by International Index of Erectile Function (IIEF)-Erectile Function Domain (EFD) scores. Aim: This analysis estimated the relationship between post-baseline IIEF-EFD scores and demographic variables, including co-morbidities, in men with ED receiving placebo in flexible-dose sildenafil studies. Methods: Placebo-treated participants in the intent-to-treat population of 42 double-blind, placebo-controlled, flexible-dose, sildenafil studies were included. A participant was classified as a placebo responder if the IIEF-EFD score was ≥26 at the last visit. Outcomes: Variables assessed were age (<45, 45-64, ≥65 years), race, body mass index, co-morbidities (cardiovascular disease/hypertension, diabetes mellitus, depression), date the last study dose was taken, study completion date, ED etiology (psychogenic, organic, mixed), history of cigarette smoking, ED duration, baseline IIEF-EFD score (≤10, 11-16, ≥17), and treatment duration. Stepwise multivariate logistic regression models assessed the odds of being a responder vs a non-responder for each variable. Results: A total of 4,360 men were included; 13.5% were responders. Odds estimates indicated the largest likelihood of placebo response occurred in men who were black (odds = 20.2, P < .0001), were younger than 45 years (odds = 7.3, P < .0001), had mild ED (baseline IIEF-EFD ≥17; odds >100, P < .0001), and did not have diabetes (odds = 4.5, P < .0001). The likelihood of a placebo response decreased as ED duration increased (odds = 0.74, P < .0001). The frequency of common adverse events was similar between placebo responders and non-responders. Clinical translation: These findings contribute to the improved understanding of predictors of placebo response in sildenafil clinical studies. Elucidation of these factors may contribute to the development of further interventions and treatment strategies and best practices for clinical trials. Strengths and conclusions: Strengths of this analysis include the large and diverse population and the duration of follow-up. Limitations include those associated with retrospective analyses and the inability to ascertain to what extent other demographic factors might have contributed to the placebo responses or how these placebo responses might be related to the natural course of ED. Conclusions: Certain demographics, co-morbidities, and condition characteristics predicted the odds of a placebo response in sildenafil clinical studies of ED. Underlying reasons behind a placebo response warrant further evaluation. Mulhall JP, Carlsson M, Stecher V, et al. Predictors of Erectile Function Normalization in Men With Erectile Dysfunction Treated With Placebo. J Sex Med 2018;XX:XXX-XXX.
Article
Background: Collagenase Clostridium histolyticum (CCH; Xiapex) injections represent the only licensed medical treatment for Peyronie's disease (PD). Aim: To evaluate the efficacy and safety of CCH injections in men with stable PD, using a modified treatment protocol and to assess partners' bother improvement in a large cohort of White-European sexually active heterosexual men treated in a single tertiary-referral center. Methods: All the 135 patients enrolled underwent a thorough assessment, which included history taking, physical examination, and pharmacologically induced artificial erection test (intra-cavernous injection) to assess the degree of penile curvature (PC) at baseline and after the completion of the treatment. Patients with calcified plaque and/or ventral curvature were excluded. All patients underwent a modified treatment protocol, which consisted of 3 intra-lesional injections of 0.9 mg of CCH performed at 4-week intervals at the point of maximum curvature. After each injection, patients were instructed to follow a strict routine involving daily penile stretching in the intervals between injections. Outcomes: International Index of Erectile Function (IIEF)-15, Global Assessment of PD, PD questionnaires (PDQ), and Female Sexual Function Index (FSFI) questionnaire were performed at baseline and at the end of treatment. Results: Overall, 135 patients completed the study protocol. Before treatment, 18 (13.33%) partners showed a degree of sexual dysfunction. Baseline median IIEF-15, FSFI, and PDQ scores were, respectively, 59.0, 35.0, and 23.0. Overall, both IIEF-total and all domains significantly improved after treatment (all P < .01). A PC mean change of 19.07 (P = .00) was measured. At the univariate linear regression analysis, IIEF-15, IIEF-erectile function, IIEF-sexual desire, and IIEF-intercourse satisfaction were positively associated with FSFI (all P ≤ .03); conversely, PDQ-penile pain, PDQ-symptom bother, and post-treament penile curvature (P ≤ .04) were associated with a decreased FSFI score. Furthermore, median change of PC was significantly associated with median change of FSFI (r = 0.25; 95% CI 0.02-0.11; P = .004). Global satisfaction after treatment was 89.6% (121/135). Clinical translation: This modified CCH treatment protocol could improve both patients' and partner's sexual function. Strength and limitations: This was an open-label, single-arm clinical study, without placebo. where only heterosexual couples in stable relationships were included. Furthermore, no real assessment of female sexual distress was carried out and long-term sexual function in both patients and female partners were not taken into account. Conclusions: The modified treatment schedule with CCH injections for stable PD has a positive impact on both patients' and partners' sexual function in heterosexual couples with a stable sexual relationship. Cocci A, Russo GI, Salonia A, et al. Predictive Factors of Patients' and Their Partners' Sexual Function Improvement After Collagenase Clostridium Histolyticum Injection for Peyronie's Disease: Results From a Multi-Center Single-Arm Study. J Sex Med 2018;15:716-721.